(Received 1 November 1955)
The work described here was started to extend knowledge of the relative effects of fluoro compounds with special reference to fluoroacetate and fluorocitrate; it was hoped that it would have particular application to effects upon the liver and to the biochemical mechanism of convulsions induced by fluorocitrate. Bartlett & Barron (1947) showed originally that acetate accumulates after fluoroacetate poisoning; but this effect is probably indirect, as Buffa & Peters (1949) found that the poisoning induced a citrate accumulation, and Peters, Wakelin, Buffa & Thomas (1953) demonstrated that this was due to the synthesis from the fluoroacetate of fluorocitrate, which blocked the tricarboxylic acid cycle at the aconitase stage. The specificity ofthis inhibition was clearly demonstrated on highly purified aconitase preparations by Morrison & Peters (1954) . This work left questions still to be answered. For instance, the livers of male rats showed no increase in citric acid concentrations as a result of fluoroacetate poisoning, according to Buffa & Peters (1949) , Potter & Busch (1950) and Fawaz & Fawaz (1953) ; but Ord & Stocken (1953) recently reported an apparent conversion of fluoroacetate into fluorocitrate by rat liver. There was also the problem why Hastings, Peters & Wakelin (1953) found no indication that convulsions induced by fluorocitrate were connected with any ionic imbalance.
[14C]Acetate was used in vivo to study inhibition of acetate metabolism as a whole. Previous work by Gould, Sinex, Rosenberg, Solomon & Hastings (1949) interesting because of its divergent action from fluoroacetate, both in vivo and in vitro.
A preliminary account of this work has appeared (Gal, Peters & Wakelin, 1954) .
METHODS
Animals. Wistar-strain male rats (body weight, 70-300 g. except in rats used for experiments of Table 4) were used except for the isotopic studies when male rats of 45-55 g.
were used exclusively. The animals, unless otherwise indicated, were fed upon a stock diet of rat cubes with water ad lib. In the experiments in vivo, the animals were killed by rapid immersion in liquid air. Organs were removed, weighed and worked up according to the requirements ofthe individual method. In the in vitro experiments pigeons and guinea pigs were also used. The rats for investigation of urinary-ketone substances were standardized over a period of 4 weeks before the actual experiment started; they received 20 g. of pellets daily at 4 p.m., and were weighed every 3 days. Every morning of the fifth week they were transferred to metabolic cages; the urine was collected between 9 a.m. and 4 p.m., and tested for ketone bodies by Rothera's test. In the sixth week they were divided into groups of three and injected with either fluoroacetate or fluorocitrate. Their collected urine was used for Rothera's test.
Citrate. This was determined by the method of Pucher, Sherman & Vickery (1936) as modified by Buffa & Peters (1949 of Gould et al. (1949) . The animals were then placed in an all-glass metabolic apparatus for collection ofC02; this was a version ofthe apparatus ofMackenzie et at. (1949) , modified to permit the collection of urine. The flow meter was discarded, the rate being set at about 70 bubbles/ min. and regulated with a fine high-vacuum stopcock. The solutions and traps were as used by Mackenzie et al. (1949) . The collection and preparation of BaCO3 was carried out as described by Popja,k (1950) with 2 cm.2 polyethylene disks (Bettix Ltd., Arrow Works, Elm Grove, London). The radioactive measurement of the BaCO3 was carried out in samples Bioch. 1956, 64 of'infinite thickness', all samples being counted in duplicate. The brain, kidney, heart and liver were worked up separately, as recommended by Calvin, Heidelberger, Reid, Tolbert & Yankwich (1949) . The rest of the organs were: pooled with the carcass. The urine samples, whenever they could be collected, were also assayed, after neutralization with NaOH to about pH 7-2 and evaporation in a desiccator in vacuo. The residue was taken up in 0-5 ml. of water, plated and dried under a heating lamp.
Measurement of radioactivity. All measurements were carried out on a Dynatron scaler unit with a thin-endwindow Geiger-Muller counter. The background varied between 12 and 18 countslmin., and was corrected for standard deviation. All samples of counts 20 times the background were counted for 30 min., recounted, and corrected for the background and total deviation. The background counts were measured for 30-45 min. at the beginning, the middle and the end of the course of the radioactive assays. The results are given ±s.D.
Chemicals. All reagents were AnalaR grade. The fluoro compounds were of analytical purity. Sodium fluoroacetate was purchased, and fluoroacetamide was given by Dr E. D. Bergmann through Dr S. Gitter. Sodium fluorocitrate was kindly given by Dr D. E. A. Rivett or synthesized according to his method (Rivett, 1953) . Enzymic fluorocitrate was prepared in the laboratory by the method of Peters et al. (1953) . Sodium fluoropyruvate was prepared from a solution of pure fluoropyruvic acid (kindly given by Mr R. Brown) by addition of an equivalent amount of 0-1 N-NaOH. Fluoropyruvic acid was also synthesized by us by a slight modification of the method of Mager & Blank (1954) and purified by microsublimation to m.p. 820.
Diethyl fluoro-oxaloacetate was prepared according to Rivett (1953) . Dimethyl fluoromalate and fluoromalamide were synthesized by Taylor & Kent (1954) particularly that in both the liver and the kidney, but especially in the liver, there is an immediate rise of citric acid following fluorocitrate injection, suggesting that it produces its action rapidly. Taken together, the interpretation appears to be that fluorocitrate penetrates the liver cells directly and so blocks the tricarboxylic acid cycle, whereas fluoroacetate, even if it penetrates, is not synthesized to fluorocitrate. This latter behaviourwould be consistent with the failure to find that fluorocitric acid is formed from fluoroacetate and oxaloacetate by pigeon-liver particles in vitro (Peters & Wakelin, 1952) . In experiments in vitro, fluorocitrate caused large accumulations of citric acid in liver homogenates.
The results with brain were somewhat equivocal. There was a quicker rise in citric acid with fluoroacetate than with fluorocitrate; but this difference is not statistically significant. Fluoroacetate gave convulsions in 30 min., whereas with fluorocitrate the animals only convulsed with a dose of 80 mg./ kg.; 40 mg./kg. did not give convulsions, nor could its action be potentiated by simultaneous administration of urea to increase penetration, or by injection of 0-8 mg. of fluoroacetate/kg.
In order to make it clear that in the rat also the intracerebral injection of fluorocitrate produces effects not given by fluoroacetate, some intracerebral injections were made in young rats with minimal doses. The previous comparison had been made on pigeons (Peters & Wakelin, 1953) , and the experiments of Dawson & Peters (1955) made for another object had been done with amounts too large to determine this point. Intracerebral injections of 1-5 pg. of fluorocitrate (enzymic) were convulsive in six animals of weight 48-55 g., whereas 10 ,ug. of fluoroacetate did nothing, except in one animal out of six (the first tried, which convulsed after 55 min., but did not die). It may be reckoned that for these animals approximately 1-2 jug. of fluorocitric acid was the limiting amount needed for producing convulsions. Table 3 gives the distribution of citric acid in brain, kidneys and the liver at death following such intracerebral injection; some of the injected fluorocitrate occasionally appears to get from the brain into the kidney, where it induces a rise of citric acid. A tendency for a similar phenomenon can be seen in the results of Dawson & Peters (1955) We have also tried several fluoro compounds along with fluoroacetylhydroxamate to find how far they interfere with the metabolism of pyruvate and acetate; the results of the intraperitoneal injections are given in Table 4 . It will be noted that the fluoroacetylhydroxamic acid produced a significant increase of citric acid only in the kidney; yet, unexpectedly, it produced convulsions which appeared 90 min. after the administration of 8 mg./kg. Much larger doses of diethyl fluoro-oxaloacetate gave the same citric picture without convulsions. Fluoromalamide produced no effect except for a small rise in kidney citrate. In all these cases it appeared that there was little if any tendency to convert any active fluoroacetyl into fluorocitrate (as judged by citrate accumulation). The most remarkable result was found with fluoropyruvate, the preliminary results of which are reported below Table 7 . Effect offluoropyruvate upon (a) the synthesi8 of citric acid from fumarate, and (b) the, metaboli&m of citric acid by kidney particl4s All conical flasks contained as a final addition 2 ml. of kidney particles (guinea pig) suspended in 1-6 ml. of 04134m-KCI and 0 4 ml. of 0-5M phosphate buffer (pH 7.2); the flask also contained 0-1 ml. of Mg2+ (4*0jumoles of MgCI2) and 0 1 ml. of ATP (1.2 ttmole) in (a) 0-2 ml. of sodium fumarate (20 moles); (b) 0*4 ml. of sodium citrate (10 lmoles); 0 134M-KCI was added to make the final volume of 3 0 ml. After shaking for 30 min. at 38 1', the reaction was stopped with 1 ml. of 25% trichloroacetic acid, and after filtration the contents of duplicate flasks were made up to 16 ml., from which samples were taken for estimation of citric acid. way to pyruvate, it should lead to fluorocitrate formation, which should both block the respiration and cause an increased accumulation of citric acid. Fluoropyruvate causes a strong inhibition of pyruvate oxidation in the pigeon-brain system (Fig. 2) . In the presence of 0 633 mMfluoropyruvate (0.2 mg./ 3 ml. in the flask) there is already an inhibition of approximately 35 % in the oxygen uptake. This is not, however, associated with an accumulation of citric acid. In the legend to Fig 2, inhibitions of citric acid formation are recorded which have been found to accompany the decrease of oxygen uptake in these experiments. These are more variable and generally greater than the inhibition of oxygen uptake. It seems clear, therefore, that there must be interference with the pyruvate-dehydrogenase step in this oxidation and that there has been no synthesis of an inhibitor for the citric acid stage of the tricarboxylic acid cycle.
Blocking agent
The inhibition of the early stage of metabolism of pyruvate has been shown again by studying the effect upon yeast decarboxylation of pyruvic acid. Table 6 shows the decrease caused by fluoropyruvate in this decarboxylation, one of three similar results with dried baker's yeast.
(ii) Kidney particle8 (guinea pig). The brainparticle experiments indicated that there was no synthesis offluorocitric acid by brain tissue; instead there was a definite interference with pyruvate oxidation which was reflected in the formation of citric acid. Since brain tissue, at any rate under these conditions, does not synthesize fluorocitric acid from fluoroacetate in the presence of pyruvate and fumarate, it was thought that the failure of fluorocitric acid synthesis should be confirmed with kidney tissue. In our ordinary experiments with fumarate alone and kidney particles, sufficient active acetyl fragments are formed to make citric acid. It has been shown that in the presence of fluoroacetate and fumarate there is an extra accumulation of citric acid owing to the synthesis of fluorocitric acid (Li6becq & Peters, 1949; Peters etal. 1953) . With fumarate there is a maximal accumulation of citrate when the preparation is blocked with fluorocitrate. On the other hand, when citrate itself is used as a substrate, fluorocitrate can be determined by its action in blocking aconitase and so preventing the disappearance of citrate. The latter has been the test eonsistently used in the isolation of fluorocitric acid. The experiments in Table 7 In the preliminary note of these experiments it was stated that the effect was not reversible, and this failure to reverse has been found in a small number of experiments; but in further work there seemed to be some conditions under which some degree of reversibility can be observed. This matter, therefore, requires further exploration. Fluoropyruvic acid (mM) Fig. 2 . Inhibition of pyruvate oxidation by fluoropyruvate in pigeon-brain particles; points at 0-633mm with centrifuged particles, the rest with uncentrifuged particles. The total volume of 3-0 ml. contained in I 0 ml. of fumarate In our studies of the rate of carbon dioxide production from acetate there was striking agreement between our values and those of Lifson & Swanson (1953) . These authors gave the rate 9.35 m-moles/ hr./100 g. of mouse, while ours, as shown in Fig. 1 , was 9 65 m-moles/hr./100 g. of rat. With fluoroacetate their rates were 5-59 m-moles/hr./100 g. for 10 mg. of fluoroacetate/kg. and 4-60 for 20 mg./kg.; ours was 4 09 m-moles/hr./100 g..for 5 mg./kg. in the rat. We found that the rate of CO2 production was 5 30 m-moles/hr./100 g. for 40 mg. of (synthetic) fluorocitrate/kg., while the rate of CO2 for fluoropyruvate (8 mg./kg.) was 8-15 m-moles/hr./100 g. In assessing the close correlation it is important to remember the wide variation in LD50, even for different strains of rat (Chenoweth, 1949) . Both fluoroacetate and fluorocitrate were given at levels causing convulsions, but fluorocitrate was much more inhibitory to the rate of production of respiratory CO2. Our results should not be interpreted as showing more than a trend.
The lack of citrate accumulation in the liver of male rats poisoned by fluoroacetate and its indication of failure to form fluorocitric acid suggested that there is a mechanism competing with the formation of fluoroacetyl-CoA. 2. In male rats, whereas generally fluoroacetate induced no rise in citric acid content of the liver, fluorocitrate injections caused immediate rise in the citric acid level.
3. Fluorocitrate when injected intracerebrally has a high toxicity for the rat, as has been shown already in pigeons and rabbits.
4. The urine from animals injected with fluorocitrate gave a marked Rothera's test.
5. Fluoroacetylhydroxamic acid when injected gave convulsions in 90 min. with only slight increases in kidney citrate. Diethyl fluoro-oxaloacetate also increased citrate in kidney, but without convulsions. Fluoromalamide gave no effect.
6. Fluoropyruvic acid when injected gave convulsions in 4 hr., with no increase in citric acid.
Several substances tried did not reverse the effect.
In vitro, fluoropyruvic acid inhibited the metabolism of pyruvic acid. 
